Adjuvante Therapie des Magenkarzinoms

Schuhmacher, C.

doi:10.1007/978-3-642-18700-1_35

C. Schuhmacher⁴

Part of the book series: Onkologie aktuell ((ONKAKTUELL))

57 Accesses

Zusammenfassung

Die theoretische Grundlage einer adjuvanten Chemotherapie bei Patienten nach kompletter Resektion (Ro-Resektion) eines Magenkarzinoms basiert darauf, okkulte, nicht im Resektat erfasste Mikrometastasen oder durch den chirurgischen Eingriff bzw. bereits vorher potenziell disseminierte Tumorzellverbände wirksam zu eliminieren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 59.99; Price excludes VAT (USA)

Softcover Book: USD 79.99; Price excludes VAT (USA)

Hardcover Book: USD 99.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Literatur

Cirera L, Balil A, Batiste E et al. (1999) Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J Clin Oncol 17:3810–3815
PubMed CAS Google Scholar
Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials. Eur J Cancer 35:1059–1064
Article PubMed CAS Google Scholar
Fink U, Schuhmacher C, Stein H et al. (1995) Preoperative chemotherapy for stage III-IV gastric carcinoma:feasability, reponse and outcome after complete resection. Br J Surg 82:1248–1252
Article PubMed CAS Google Scholar
Hermans J, Bonenkamp JJ, Boon MC et al. (1993) Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomised trials. J Clin Oncol 11:1441–1447
PubMed CAS Google Scholar
Kim R, Yoshida K, Toge T (2002) Current status and future perspectives of post-operative adjuvant therapy for gastric carcinoma Anticancer Research 22:283–290
CAS Google Scholar
Macdonald J, Smalley J, Benedetti J et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725–730
Article PubMed CAS Google Scholar
Neri B, Cini G, Andreoli F et al. (2001) Randomised trial of adjuvant chemotherapy vs. control after curative resection for gastric cancer: 5 year follow up. Br J Cancer 84:878–880
Article PubMed CAS Google Scholar
Siewert JR, Böttcher K, Stein H, Roder JD and the German Gastric Cancer Study Group (1998) Relevant prognostic factors in gastric cancer. Ann Surg 228:449–461
Article PubMed CAS Google Scholar
Smalley S, Gunderson L (1992) Stomach. In: Perez C, Brady L (eds) Principles and practice of radiation oncology, 2nd edn. Lippincott, Philadelphia, pp 970–984
Google Scholar
Valle JW (2001) Adjuvant therapy for gastric cancer-has the standard changed? Br J Cancer 84:875–877
Article PubMed CAS Google Scholar

Download references

Author information

Authors and Affiliations

Chirurgische Klinik und Poliklinik Klinikum rechts der Isar, der Technischen Universität München, Ismaninger Straße 22, 81675, München, Germany
Dr. med. C. Schuhmacher

Authors

Dr. med. C. Schuhmacher
View author publications
You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Schuhmacher, C. (2004). Adjuvante Therapie des Magenkarzinoms. In: Management des Magen- und Ösophaguskarzinoms. Onkologie aktuell. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18700-1_35

Download citation

DOI: https://doi.org/10.1007/978-3-642-18700-1_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62254-0
Online ISBN: 978-3-642-18700-1
eBook Packages: Springer Book Archive

Publish with us

Policies and ethics